Catheterization and Cardiovascular Interventions (CCI) Journal Publishes Sahajanand Medical Technologies PAINT Trial 1 Year Results
“The 74th issue of prestigious international journal Catheterization and Cardiovascular Interventions published an article of Sahajanand Medical Technologies PAINT (PercutAneous INTervention) Trial - A randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (Paclitaxel or Sirolimus) compared against Bare stents: 1-year result.” - November 01, 2009
Six Month Clinical Outcomes of SMT’s Supralimus-Sirolimus Eluting Stent with a Biodegradable Polymer is Presented at EuroPCR 09
Six Month Clinical Outcomes of SMT’s Supralimus-Sirolimus Eluting Stent with a Biodegradable Polymer (part of the prospective Multicenter E-Series Registry) is presented at EuroPCR 2009. - July 01, 2009
Sahajanand Medical Technologies’ Sirolimus Eluting Stent Shows Excellent Outcomes
Sirolimus Eluting Stent for leading Drug Eluting Stents developer & manufacturer Sahajanand Medical Technologies displayed positive results in MAXIMUS trial that included 100 patients from the Max Heart Institute in India. - October 20, 2008
Sahajanand Medical Technologies Wins Golden Jubilee Award 06-07 for Their Outstanding Performance in Export Small Scale Chemical & Pharmaceuticals
For their outstanding performance, Sahajanand Medical Technologies has been awarded with Golden Jubilee Award 06-07 in the field of Export of Medical devices Small Scale Chemical & Pharmaceuticals. The Golden Jubilee Memorial Trust Awards are presented every year by The South Gujarat Chamber of Commerce & Industry (SGCCI) recognizing the excellence in the meritorious performance in various aspects of business. Awards were presented at the Annual General Meeting of SGCCI on 8th June 08. - June 28, 2008
(Sahajanand Medical Technologies) PAINT Trial Results Support Safety and Efficacy of the Infinnium and Supralimus Stents
Sahajanand Medical Technologies received positive results of nine month PAINT trials for Drug eluting stents, Infinnium and Supralimus. The results unveiled during plenary session of EuroPCR 2008-Barcelona. - May 16, 2008